Home・Aandelen Lijst・Anika Therapeutics Inc

Anika Therapeutics Inc

Gesloten

SectorGezondheidszorg

21.4 7.48

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

20.54

Max

21.4

Belangrijke statistieken
By Trading Economics
Inkomsten	8.4M 3.3M
Verkoop	3M 33M
EPS	0.3
Winstmarge	10.147
Werknemers	235
EBITDA	8.3M 4.9M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	-1.96% downside

Dividenden
By Acuity
Volgende Winsten	4 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	79M 277M
Vorige openingsprijs	13.92
Vorige sluitingsprijs	21.4

Nieuwssentiment

By Acuity

92%

5 / 340 Rangschikking in Healthcare

Anika Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 aug 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 aug 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 aug 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 aug 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 aug 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 jul 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

30 jul 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains and maintaining strength above the 20-day moving average.

29 jul 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, amid notable volatility earlier. The stock remains above its 20-day moving average.

28 jul 2026, 19:36 UTC

Anika Therapeutics Inc shares are higher today, continuing a positive trend since Monday's close. The stock recently pulled back from earlier session highs.

27 jul 2026, 18:06 UTC

Anika Therapeutics Inc shares are higher Monday, reflecting a cumulative gain since Friday, amid broader market volatility influenced by declining oil prices.

24 jul 2026, 20:06 UTC

Anika Therapeutics Inc shares are higher today amid a positive market backdrop, despite some intraday volatility earlier in the session. No specific news was identified.

22 jul 2026, 20:13 UTC

Anika Therapeutics Inc. shares are lower in after-market trading, reflecting weak performance and broader market volatility amid rising crude oil prices.

21 jul 2026, 18:56 UTC

Anika Therapeutics Inc is trading higher, reflecting positive market sentiment, despite some intraday volatility earlier in the session. The stock remains elevated since Monday's close.

20 jul 2026, 19:06 UTC

Anika Therapeutics Inc shares are lower today, continuing a trend of declines over the past three sessions amid a broader market downturn in U.S. Treasuries.

Peer Vergelijking

Prijswijziging

Anika Therapeutics Inc Prognose

Koersdoel

By TipRanks

-1.96% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 21 USD -1.96%

Hoogste 21 USD

Laagste 21 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Anika Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Anika Therapeutics Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

5 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.